Filana Therapeutics, Inc. (FLNA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.7481−$0.0247 (−3.20%) on the dayAs of the close; data may be delayed.
FLNA price, last 12 months
Key stats
- Previous close
- $0.7728
- Open
- $0.7799
- Day range
- $0.7401 – $0.7799
- 52-week range
- $0.6701 – $2.27
- Volume
- 779.5K
- Avg volume (20 days)
- 5.4M
- Market cap
- $36.1M
Performance
1W+3.0%
1M−19.1%
3M−37.7%
6M−57.7%
YTD—
1Y—
Technicals and fundamentals
About Filana Therapeutics, Inc.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $36.1M